Vidaeff, A. C., Ramin, S. M., Gilstrap, L. C. 3rd & Alcorn, J. L. Characterization of corticosteroid redosing in an in vitro cell line model.
In vitro cell line studies revealed markedly better drug uptake along with safer and biocompatible nature of CSNEOFs than free drug suspension.
In vitro cell line studies performed on HT-29 and Colo-320 colon cancer cells revealed a reduced IC50 even in MDR cells.
In vitro cell line studies are in progress.
On the basis of results obtained, the glutaraldehyde-mediated conjugation was selected for further in vitro cell line studies.
Firstly, since many findings were from in vitro cell line studies or current database, further validation studies in clinical settings will be of great importance.
PF-03084014, a γ-secretase inhibitor, was tested against the PPTP in vitro cell line panel (1.0 nM to 10 μM) and against the in vivo xenograft panels (administered orally twice daily on Days 1-7 and 15-21).
The in vitro cell line studies conducted on highly metastatic B16F10 cells demonstrated the superior antimigratory and antiadhesive activity of EILDV-conjugated micelles by virtue of their receptor-mediated endocytosis mechanism.
In vitro drug release study and in vitro cell line studies such as cytotoxicity assay were conducted using A549 cell line to evaluate in vitro formulation performance in comparison to the plain drug.
In vitro cell line studies have shown decreased mitochondrial function and oxidative stress after exposure to ZnO NPs in human embryonic lung fibroblasts (HELF) cells[7], human epidermal (A431) cells[8], human colon carcinoma (LoVo) cells[9], human lung bronchial epithelial (BEAS-2B) cells[10], hepatocellular carcinoma SMMC-77211) cells[11], and human osteoblast cancer cell line[12].
For in vitro cell line, six cell lines had been screened.
